Abstract A prospective study of 75 patients undergoing cataract surgery was conducted to identify the cause of postoperative conjunctival chemosis seen in patients with cataracts in this department. The patients were split in three groups of 25 each. Group G patients were given a subconjunctival injection of gentamicin at the end ofthe cataract procedure; group W patients did not receive subconjunctival gentamicin, but a cellulose wick drain was used during the procedure; and Group GW patients received a subconjunctival injection of gentamicin and a wick drain was also used. The incidence, severity, and the duration of chemosis were observed in the three groups. Chemosis was seen only in groups G and GW, and the difference between the number of patients who received gentamicin and those who did not receive gentamicin was significant
was always involved pointed to two surgical events occurring exclusively in this area. One was the insertion of a cellulose wick to drain fluid away from the operative field during the operation, and the other was the subconjuctival injection of gentamicin at the end of the operation. This prospective study was set up to investigate whether one or both of these surgical events were giving rise to the chemosis.
Patients and methods
Patients undergoing extracapsular cataract extractions between 21 September 1989 and 19 January 1990 at the Hull Royal Infirmary were included. Their ages ranged from 44 to 88 years (mean 74-67 years). A total of 75 eyes of 75 patients were enrolled into this study.
Patients who had a past history of conjunctival chemosis, chemical burn, conjunctival trauma, keratoconjunctivitis sicca, and conjunctival lesions in the form of scarring and symblepharon were excluded from this study.
The patients were all waiting list admissions and were sequentially allocated on admission into three groups as follows. Each group consisted of 25 patients. Group G. Patients given a subeonjunctival injection of 20 mg of gentamicin (Cidomycin) in the lower fornix at the end of surgery. Wick was not used during surgery. Group W. A wick was inserted into the lower fornix during surgery. Patients did not get a conjunctival injection at the end of the operation. Group GW. A wick and a subconjunctival injection were used as described above.
All patients underwent endocapsular or extracapsular cataract surgery under general anaesthesia by three surgeons using a manual aspiration technique. The duration of wick contact was recorded in patients of groups W and GW1, and a 20 mg subconjunctival injection of gentamicin was given to patients in groups G and GW.
The conjunctival sacs of patients were examined and the presence or absence of chemosis was noted. If present the severity was noted in accordance with the following criteria: grade 1 -involvement limited to 10%'o to 30o of the conjunctiva; grade 2 -involvement limited to 30% to 70% to the conjunctiva; grade 3 -involvement limited to 70% to 100% of the conjunctiva.
The patients were examined daily while on the ward and the trend of chemosis noted. They were again examined for chemosis on their first postoperative clinic visit. During his examination of them the observer did not know to which groups the patients had been allocated.
Postoperative conjunctival chemosis in cataract surgery caused by subconjunctival gentamicin injection Table 2 shows the severity of chemosis in the three groups. In group G of the 25 cases 7 (28%) had grade 1 chemosis, 13 (52%) had grade 2 chemosis, 3 (12%) had grade 3 chemosis, and 2 (8%) had no chemosis. In group GW of the 25 cases 6 (24%) had grade 1 chemosis, 13 (52%) had grade 2 chemosis, 3 (12%) had grade 3 chemosis, and 3 (12%) had no chemosis. In group W none of the 25 cases had chemosis. There is no statistically significant difference in the incidence of the three grades of chemosis between groups G and GW, indicating that the use of the wick did not influence the severity of chemosis in group GW. The conclusion is strongly supported by the fact that no chemosis was seen in any of the cases in group W, where only the wick was used. Table 3 shows the duration of chemosis seen in the 45 patients in groups G and GW who had chemosis. The duration of chemosis in these 45 patients ranged from three to seven days, average 4-64 days.
Discussion
The cause ofpostoperative conjunctival chemosis in this study was the use of subconjunctival gentamicin injection at the end of the cataract operation. The cellulose wick drain did not influence the chemosis in any way.
The prophylactic use of subconjunctival The gentamicin preparation used in this study, gentamicin injectable 80 mg in 2 ml (Cidomycin), is widely used for the purpose of subconjunctival injections in this country. The manufacturers do not recommend the use of this preparation for subconjunctival use. Their recommended preparation for subconjunctival use in the prophylaxis prior to intraocular surgery is gentamicin sterile powder (Cidomycin), available in packs of 1 g.8 The author believes this is not used as widely as the gentamicin injectable preparation. The difference between the two preparations is that gentamicin injectable has sodium metabisulphate, methyl hydroxybenzoate, propyl hydroxybenzoate, and disodium edetate as additives, while the recommended preparation gentamicin sterile powder has no additives.
Jenkins et al9 in 1990 studied the comparative conjunctival toxicity of subconjunctival gentamicin and cefuroxime in a single-blind trial. They reported greater conjunctival toxicity in the form of hyperaemia, conjunctival oedema and capillary closure with subconjunctival gentamicin. The greater toxicity of gentamicin reported in their study may reflect the fact that the gentamicin preparation used, gentamicin injectable (Cidomycin), had the additives mentioned above, while the cefuroxime (Glaxo) preparation used in their study had no additives at all.
The possibility of the additives in the gentamicin preparation having a causative role in the conjunctival toxicity observed both in the present study and in the study by Jenkins et al9 cannot be ruled out. A follow-up study to assess the role of additives in gentamicin toxicity is being conducted in this department.
The cause of postoperative conjunctival chemosis in our study was the subconjunctival injection of gentamicin given at the end of the cataract operation. The 
